PharmaTimes | Nachrichten

❌

Mehr »

Montag, 23.07.2018 Börsentäglich über 12.000 News von 588 internationalen Medien

Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Xetra-Orderbuch

Devisen	Kurs	%

Rohstoffe	Kurs	%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)

Aufklappen

Schliessen

Zeit	Aktuelle Nachrichten
Fr	PureTech lifted by news of Roche deal
Fr	UK drug advisors recommend rescheduling of medical cannabis
Fr	Allergan, Molecular Partners' AMD drug non-inferior to Lucentis
Fr	NICE backs radionuclide therapy for some neuroendocrine tumours
Do	Be recognised for the part you play in targets being met
Do	Industry shows support for new Medical & Scientific Excellence Awards
Do	Want to make a difference? Enter the new Charity Challenge
Do	Fly your company's flag - ENTER NOW
Do	Sub-cutaneous form of Entyvio hits PhIII safety, efficacy goals
Do	Owlstone Medical appoints five leading experts to Scientific Advisory Board
Do	Kisqali wins speedy US breast cancer nod
Do	Four pharmas named for breaching ABPI Code of Practice
Do	Dementia accounts for 13 percent of total UK deaths
Do	Novartis bags rights to Galapagos/MorphoSys atopic dermatitis drug
Mi	Silence Therapeutics appoints David Horn Solomon as CEO
Mi	NICE calls for quicker treatment of kidney stone patients in pain
Mi	Record numbers taking part in life sciences industry research
Mi	US approves Janssen's HIV pill Symtuza
Mi	11 London makes 3 new senior hires
Di	Roche's antiviral hits flu targets in PhIII trial
Di	Pfizer kicks off PhIII programme for haemophilia B gene therapy
Di	UK panel says human embryo editing 'morally permissable'
Di	NICE issues cerebral palsy guideline for adults
Di	EU approval for Akcea/Ionis' rare disease therapy
16.07.	Enter now and showcase your talents industry-wide

Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von

Aktuelle News von PharmaTimes